Thrombosis and cancer Archives

Home › Thrombosis and cancer

PATIENTS’ EXPERIENCE OF LIVING WITH CANCER-ASSOCIATED THROMBOSIS: THE PELICAN PROJECT

The clinical issues and the main consequences of venous thromboembolism (VTE) in patients with cancer are nowadays well...

Venous thromboembolism (VTE) is a frequent complication and the second leading cause of death in cancer patients....

What is the physician perception and common practice in treatment of venous thromboembolism (VTE) in cancer patients?...

Value and limitations of low-molecular-weight heparins Following the demonstration that vitamin K antagonists (VKA) are...

It is well known that patients with cancer are at high risk of venous thromboembolism (VTE), especially when initiating...

Venous thromboembolism (VTE) is a recurrent risk factor in cancer patients. In particular, patients with hematologic...

Continued rapid advancement in cancer treatment and early cancer detection have resulted in a steady growth of the...

The HYPERCAN (HYPERcoagulation in CANcer) study (registered at www.clinicaltrials.gov; NCT02622815) is an ongoing,...

In a recent issue of the Journal of Thrombosis and Hemostasis, we report that cancer patients with isolated distal deep...

Extracellular vesicles (EV) are submicron vesicles released from activated cells, apoptotic cells and cancer cells...